Filing Details
- Accession Number:
- 0000914190-13-000563
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-27 17:58:14
- Reporting Period:
- 2013-08-23
- Filing Date:
- 2013-08-27
- Accepted Time:
- 2013-08-27 17:58:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180145 | Cardiovascular Systems Inc | CSII | Surgical & Medical Instruments & Apparatus (3841) | 411698056 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1427556 | E James Flaherty | 651 Campus Drive St. Paul MN 55112 | Chief Administrative Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-08-23 | 1,907 | $20.88 | 136,638 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-08-26 | 4,213 | $21.29 | 132,425 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-08-27 | 2,931 | $20.88 | 129,494 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $8.83 | 2017-04-17 | 8,624 | 8,624 | Direct | |
| Common Stock | Stock Option (right to buy) | $7.90 | 2017-08-06 | 19,388 | 19,388 | Direct | |
| Common Stock | Stock Option (right to buy) | $12.15 | 2017-12-11 | 24,120 | 24,120 | Direct | |
| Common Stock | Stock Option (right to buy) | $8.75 | 2019-03-02 | 10,999 | 10,999 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2017-04-17 | 8,624 | 8,624 | Direct |
| 2017-08-06 | 19,388 | 19,388 | Direct |
| 2017-12-11 | 24,120 | 24,120 | Direct |
| 2019-03-02 | 10,999 | 10,999 | Direct |
Footnotes
- In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.59 to $21.06 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.87 to $21.48 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.80 to $21.03 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Fully exercisable.
Billionaire Hedge Funds
